AJMC September 13, 2024
Laura Joszt, MA

Panelists discussed how the Inflation Reduction Act and the Enhancing Oncology Model are impacting value in cancer care and access to treatment.

With the Inflation Reduction Act (IRA) now being implemented and the Enhancing Oncology Model (EOM) enacting changes and opening up for a second round of applications to join, a panel of experts at the Patient-Centered Oncology Care® meeting discussed what is improving access, impacting innovation, and creating value in cancer care.

Ryan Haumschild, PharmD, MS, MBA, CPEL, vice president of pharmacy, Emory Healthcare and Winship Cancer Institute, moderated the discussion and was joined by:

  • Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA, clinical pharmacy manager, Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Cancer Center
  • Bruce Wilson,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Conferences / Podcast, Provider, Trends
Opinion: Extending Medicare coverage to obesity medications is imperative
3 addiction and drug policy issues to watch in 2025
Transforming the in-hospital experience with interoperability
Virtual Nursing is Here, Whether You Like It or Not
Does Forward Health's failure mark the winter of telehealth?

Share This Article